RetinaOS
Discover clinical workflow and inventory management system built for the changing demands of today’s Retina practices.
Growing a retina practice today requires more than clinical excellence. With increasing demands from regulatory changes, drug pricing shifts, and operational complexities, retina specialists need strong business support to stay independent and thrive. That’s where McKesson comes in.
We help you navigate the business side of your practice with solutions like RetinaOS and the Onmark® Vision GPO program—designed specifically for retina specialists. Our comprehensive approach combines deep industry expertise, actionable insights, and a portfolio of services that drive efficiency, profitability, and long-term practice growth.
Every customer is paired with a dedicated expert account executive who simplifies the way you work with McKesson and serves as your direct point of contact. Whether you need strategic guidance or day-to-day support, your account executive is there to help you make confident decisions and stay focused on delivering exceptional patient care.
With McKesson, you have access to solutions you need, when you need them—backed by a partner who’s invested in your success.
Discover clinical workflow and inventory management system built for the changing demands of today’s Retina practices.
Be part of an exclusive GPO program to secure better pricing on key retina products.
Advance financial health and clinical excellence with in-house expert consulting and support.
Access to key retina drugs as they become available.
Help patients navigate the financial landscape while providing access to the best treatment plans.
Inventory is vital to the success of your practice. What if you had clearer visibility into the metrics that truly matter? Introducing RetinaOS — a cloud-based platform designed to modernize inventory management for today’s Retina practices.
Want more tech? Discover an entire portfolio of technologies designed to help you run an efficient and successful practice.
Supercharge your buying power. Join an exclusive GPO community with 50+ retina practices and be part of a $2+ billion purchasing group built by and for physicians.
This collaborative network’s goal is to deliver significant cost savings for your practice and help you get the best economics on essential retina drug products, ultimately enhancing your practice's financial health.
We work closely with our biopharma partners to negotiate better contract structures that maximize performance, aiming to provide you with the most advantageous terms and support for your needs.
PRISM Vision Group is supported by McKesson. Together, we provide practices with access to vital resources and proven business strategies - delivering an end-to-end solution for practice management and growth. This powerful collaboration allows you to dedicate your time to what truly matters most: enhancing the health and vision of your patients and advancing the science of eye care.
Hear from members Shaun Brierly, MD, Chief Medical Officer at American Vision Partners, and Courtney Sheppard, CFO at Mid-Atlantic Retina, as they share how Onmark Vision makes a difference at their practices.
Interested in learning how it could work for yours? Let’s talk.
Our pharmacy experts can help you drive clinical value for better patient outcomes through education and training including:
Our team of field-based problem-solvers have a deep expertise in community care and a commitment to understanding your practice. Through education, training and one-on-one customized services, we help practices like yours fulfill your business goals by:
McKesson offers differentiated contracts and access to key retina drugs as they become available, helping practices stay competitive and clinically current. Our experts support operational readiness, from infrastructure planning to clinical training, and more.
This Retinal Physician article, authored by our clinical advisors, outlines how retina practices can successfully implement biosimilars through planning and education.
A community retina practice partnered with our Onmark® GPO experts to adopt a biosimilar therapy, saving $1 million in the first quarter and projecting $4 million annually. As a result, the practice boosted its cash flow and gained more independence, enabling it to expand by hiring another physician.
As retinal disease treatments grow increasingly complex and costly, patient assistance programs have become essential lifelines for both patients and the practices that serve them. These programs help offset the financial burden of high-cost therapies. However, recent disruptions in funding have left many retina practices scrambling to maintain access to care and financial stability. In this evolving landscape, it is more critical than ever for providers to stay informed, counsel patients proactively, and explore innovative strategies to navigate funding gaps and preserve clinical excellence.
With medication costs rising and patient assistance programs facing financial uncertainty, it’s critically important for practices to take action to help their patients get necessary treatment and proactively adapt to changes in the marketplace.
Discover a tool that helps you evaluate the financial impact to both your practice and patients by analyzing different treatment regimens and payer fee schedules while eliminating the financial unknown for patients with a cost of care estimate that’s easy to understand.